Literature DB >> 7496949

Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome patients.

P K Peterson1, S A Sirr, F C Grammith, C H Schenck, A M Pheley, S Hu, C C Chao.   

Abstract

Chronic fatigue syndrome (CFS) is an idiopathic disorder characterized by fatigue that is markedly exacerbated by physical exertion. In the present study, we tested the hypothesis that mild exercise (walking 1 mph [1 mile = 1.609 km] for 30 min) would provoke serum cytokine and cerebral blood flow abnormalities of potential pathogenic importance in CFS. Interleukin-1 beta, interleukin-6, and tumor necrosis factor alpha were nondetectable in sera of CFS patients (n = 10) and healthy control subjects (n = 10) pre- and postexercise. At rest, serum transforming growth factor beta (TGF-beta) levels were elevated in the CFS group compared with the control group (287 +/- 18 versus 115 +/- 5 pg/ml, respectively; P < 0.01). Serum TGF-beta and cerebral blood flow abnormalities, detected by single-photon emission-computed tomographic scanning, were accentuated postexercise in the CFS group. Although these findings were not significantly different from those in the control group, the effect of exercise on serum TGF-beta and cerebral blood flow appeared magnified in the CFS patients. Results of this study encourage future research on the interaction of physical exertion, serum cytokines, and cerebral blood flow in CFS that will adopt a more rigorous exercise program than the one used in this study.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7496949      PMCID: PMC368231          DOI: 10.1128/cdli.1.2.222-226.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  14 in total

Review 1.  Immunology of postviral fatigue syndrome.

Authors:  J F Mowbray; G E Yousef
Journal:  Br Med Bull       Date:  1991-10       Impact factor: 4.291

2.  Immunologically mediated fatigue: a murine model.

Authors:  C C Chao; M DeLaHunt; S Hu; K Close; P K Peterson
Journal:  Clin Immunol Immunopathol       Date:  1992-08

3.  Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects.

Authors:  A Lloyd; I Hickie; A Brockman; J Dwyer; D Wakefield
Journal:  J Infect Dis       Date:  1991-11       Impact factor: 5.226

4.  Circulating lymphokine levels in the chronic fatigue syndrome.

Authors:  S E Straus; J K Dale; J B Peter; C A Dinarello
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

Review 5.  Transforming growth factor beta.

Authors:  A B Roberts; M B Sporn
Journal:  Adv Cancer Res       Date:  1988       Impact factor: 6.242

6.  NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment.

Authors:  A Schluederberg; S E Straus; P Peterson; S Blumenthal; A L Komaroff; S B Spring; A Landay; D Buchwald
Journal:  Ann Intern Med       Date:  1992-08-15       Impact factor: 25.391

7.  Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome.

Authors:  C C Chao; E N Janoff; S X Hu; K Thomas; M Gallagher; M Tsang; P K Peterson
Journal:  Cytokine       Date:  1991-07       Impact factor: 3.861

8.  Chronic fatigue syndrome in Minnesota.

Authors:  P K Peterson; C H Schenck; R Sherman
Journal:  Minn Med       Date:  1991-05

Review 9.  Cytokines and neuropathology.

Authors:  M C Morganti-Kossmann; T Kossmann; S M Wahl
Journal:  Trends Pharmacol Sci       Date:  1992-07       Impact factor: 14.819

10.  Computerized administration of the Diagnostic Interview Schedule.

Authors:  A G Blouin; E L Perez; J H Blouin
Journal:  Psychiatry Res       Date:  1988-03       Impact factor: 3.222

View more
  18 in total

1.  Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion.

Authors:  J J LaManca; S A Sisto; X D Zhou; J E Ottenweller; S Cook; A Peckerman; Q Zhang; T N Denny; W C Gause; B H Natelson
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

2.  Cytokine responses to exercise and activity in patients with chronic fatigue syndrome: case-control study.

Authors:  L V Clark; M Buckland; G Murphy; N Taylor; V Vleck; C Mein; E Wozniak; M Smuk; P D White
Journal:  Clin Exp Immunol       Date:  2017-10-11       Impact factor: 4.330

Review 3.  Evidence for the presence of immune dysfunction in chronic fatigue syndrome.

Authors:  Benjamin H Natelson; Mohammad H Haghighi; Nicholas M Ponzio
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

4.  Acute phase responses and cytokine secretion in chronic fatigue syndrome.

Authors:  J G Cannon; J B Angel; R W Ball; L W Abad; L Fagioli; A L Komaroff
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

5.  Reply to Roerink et al: Methods for recruitment, serum separation, and storage were the same for patients and controls.

Authors:  Jose G Montoya; Holden T Maecker; Yael Rosenberg-Hasson; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-30       Impact factor: 11.205

6.  Cerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labeling.

Authors:  Bharat Biswal; Pratap Kunwar; Benjamin H Natelson
Journal:  J Neurol Sci       Date:  2010-12-16       Impact factor: 3.181

7.  Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome.

Authors:  A L Bennett; C C Chao; S Hu; D Buchwald; L R Fagioli; P H Schur; P K Peterson; A L Komaroff
Journal:  J Clin Immunol       Date:  1997-03       Impact factor: 8.317

Review 8.  Chronic fatigue syndrome: an update.

Authors:  R J Shephard
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 9.  Exercise and fatigue.

Authors:  Wim Ament; Gijsbertus J Verkerke
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

Review 10.  Effect of Acute Exercise on Fatigue in People with ME/CFS/SEID: A Meta-analysis.

Authors:  Bryan D Loy; Patrick J O'Connor; Rodney K Dishman
Journal:  Med Sci Sports Exerc       Date:  2016-10       Impact factor: 5.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.